This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: Suzhou Connect Biopharmaceuticals, Ltd.. Active years: 2020-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2024
Title: Limin Zhang: Innovator in Biopharmaceuticals
Introduction
Limin Zhang is a prominent inventor based in Taicang, China. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of antibodies for medical applications. With a total of 2 patents to his name, Zhang is recognized for his innovative work in binding to interleukin receptors.
Latest Patents
Zhang's latest patents include an antibody capable of binding to the interleukin 4 (IL-4) receptor. This invention discloses a nucleic acid sequence encoding the antibody, a vector that includes the nucleic acid sequence, and a host cell that has been transformed or transfected with the vector. Additionally, the patent provides a method for producing the antibody, outlines its medical uses, and includes a kit featuring the antibody.
Career Highlights
Limin Zhang is currently employed at Suzhou Connect Biopharmaceuticals, Ltd. His work at this company has allowed him to focus on groundbreaking research and development in the biopharmaceutical sector. His expertise in antibody development has positioned him as a key player in the industry.
Collaborations
Zhang collaborates with notable colleagues such as Wei Zheng and Wubin Pan. These partnerships enhance the innovative potential of their projects and contribute to the advancement of biopharmaceutical research.
Conclusion
Limin Zhang's contributions to the field of biopharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments and therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile